Casdin Capital, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Casdin Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $3.37 Million - $4.3 Million	-65,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $2.78 Million - $4.88 Million	-75,000 Reduced 53.57%	65,000 $3.88 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $3.87 Million - $7.98 Million	-115,000 Reduced 45.1%	140,000 $5.76 Million
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $4.91 Million - $10.8 Million	155,000 Added 155.0%	255,000 $15.9 Million
Q3 2019 Nov 12, 2019	BUY	$19.95 - $38.85 $2 Million - $3.89 Million	100,000 New	100,000 $3.39 Billion

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.